 Eric Hink
Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Orbital Fractures | 4 | 2017 | 8 | 1.390 |
Why?
| | Oculomotor Muscles | 3 | 2017 | 37 | 0.990 |
Why?
| | Eye Infections, Bacterial | 4 | 2015 | 27 | 0.920 |
Why?
| | Eyelids | 5 | 2015 | 18 | 0.910 |
Why?
| | Orbit | 4 | 2017 | 42 | 0.890 |
Why?
| | Ophthalmologic Surgical Procedures | 7 | 2015 | 55 | 0.890 |
Why?
| | Eye Infections, Fungal | 3 | 2017 | 6 | 0.870 |
Why?
| | Orbital Diseases | 2 | 2017 | 21 | 0.850 |
Why?
| | Eyelid Diseases | 3 | 2015 | 12 | 0.750 |
Why?
| | Sphenoid Bone | 1 | 2017 | 18 | 0.690 |
Why?
| | Skull Neoplasms | 1 | 2017 | 25 | 0.690 |
Why?
| | Meningioma | 1 | 2017 | 68 | 0.650 |
Why?
| | Blepharophimosis | 1 | 2013 | 4 | 0.540 |
Why?
| | Candidiasis | 1 | 2013 | 59 | 0.520 |
Why?
| | Eye Injuries | 2 | 2014 | 45 | 0.500 |
Why?
| | Reconstructive Surgical Procedures | 2 | 2013 | 259 | 0.450 |
Why?
| | Orbital Cellulitis | 3 | 2015 | 11 | 0.450 |
Why?
| | Conjunctiva | 1 | 2011 | 52 | 0.440 |
Why?
| | Surgical Wound Infection | 1 | 2013 | 223 | 0.430 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2013 | 269 | 0.390 |
Why?
| | Golf | 1 | 2008 | 4 | 0.380 |
Why?
| | Tomography, X-Ray Computed | 9 | 2017 | 2371 | 0.340 |
Why?
| | Inflammation | 1 | 2017 | 2427 | 0.310 |
Why?
| | Orbital Neoplasms | 3 | 2015 | 21 | 0.270 |
Why?
| | Child, Preschool | 10 | 2017 | 9655 | 0.270 |
Why?
| | Surgical Flaps | 3 | 2015 | 126 | 0.260 |
Why?
| | Dacryocystorhinostomy | 2 | 2015 | 9 | 0.240 |
Why?
| | Prostheses and Implants | 2 | 2014 | 157 | 0.240 |
Why?
| | Mucormycosis | 2 | 2017 | 21 | 0.210 |
Why?
| | Adolescent | 13 | 2017 | 18579 | 0.210 |
Why?
| | Cicatrix | 2 | 2017 | 57 | 0.200 |
Why?
| | Child | 11 | 2017 | 17358 | 0.200 |
Why?
| | Eye Pain | 2 | 2017 | 8 | 0.200 |
Why?
| | Retrospective Studies | 9 | 2017 | 11118 | 0.190 |
Why?
| | Neoplasm Invasiveness | 2 | 2017 | 453 | 0.180 |
Why?
| | Mucocele | 1 | 2017 | 12 | 0.180 |
Why?
| | Mucorales | 1 | 2017 | 1 | 0.180 |
Why?
| | Graves Ophthalmopathy | 1 | 2017 | 3 | 0.180 |
Why?
| | Paranasal Sinus Diseases | 1 | 2017 | 14 | 0.170 |
Why?
| | Nose Diseases | 1 | 2017 | 11 | 0.170 |
Why?
| | Conjunctival Diseases | 1 | 2017 | 16 | 0.170 |
Why?
| | Floods | 1 | 2017 | 14 | 0.170 |
Why?
| | Visual Acuity | 4 | 2017 | 248 | 0.170 |
Why?
| | Amnion | 1 | 2017 | 28 | 0.170 |
Why?
| | Soft Tissue Injuries | 1 | 2017 | 33 | 0.170 |
Why?
| | Receptor, IGF Type 1 | 1 | 2017 | 59 | 0.170 |
Why?
| | Corneal Diseases | 1 | 2017 | 40 | 0.170 |
Why?
| | Stevens-Johnson Syndrome | 1 | 2017 | 36 | 0.170 |
Why?
| | Craniotomy | 1 | 2017 | 65 | 0.170 |
Why?
| | Endoscopy | 2 | 2017 | 238 | 0.160 |
Why?
| | Infant | 6 | 2017 | 8024 | 0.160 |
Why?
| | Humans | 26 | 2017 | 112255 | 0.160 |
Why?
| | Disasters | 1 | 2017 | 86 | 0.160 |
Why?
| | Streptococcal Infections | 3 | 2015 | 139 | 0.160 |
Why?
| | Vision Disorders | 1 | 2017 | 119 | 0.160 |
Why?
| | Diagnosis, Differential | 3 | 2017 | 1430 | 0.150 |
Why?
| | Lacrimal Duct Obstruction | 1 | 2015 | 4 | 0.150 |
Why?
| | Cavernous Sinus Thrombosis | 1 | 2015 | 9 | 0.150 |
Why?
| | Lacrimal Apparatus | 1 | 2015 | 8 | 0.150 |
Why?
| | Polyglycolic Acid | 1 | 2015 | 44 | 0.150 |
Why?
| | Absorbable Implants | 1 | 2015 | 41 | 0.150 |
Why?
| | Female | 17 | 2017 | 62627 | 0.150 |
Why?
| | Biopsy | 2 | 2017 | 1065 | 0.140 |
Why?
| | Immunologic Factors | 1 | 2017 | 217 | 0.140 |
Why?
| | Prednisone | 1 | 2015 | 245 | 0.140 |
Why?
| | ACTH-Secreting Pituitary Adenoma | 1 | 2014 | 6 | 0.140 |
Why?
| | Facial Paralysis | 1 | 2014 | 14 | 0.140 |
Why?
| | Exophthalmos | 2 | 2017 | 13 | 0.140 |
Why?
| | Magnetic Resonance Imaging | 5 | 2017 | 3019 | 0.140 |
Why?
| | Platinum | 1 | 2014 | 29 | 0.140 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2015 | 160 | 0.140 |
Why?
| | Surgery, Plastic | 1 | 2013 | 23 | 0.130 |
Why?
| | Mycobacterium chelonae | 1 | 2013 | 9 | 0.130 |
Why?
| | School Admission Criteria | 1 | 2013 | 29 | 0.130 |
Why?
| | Silicone Elastomers | 1 | 2013 | 7 | 0.130 |
Why?
| | Osteotomy | 1 | 2015 | 138 | 0.130 |
Why?
| | Jaw Fractures | 1 | 2013 | 2 | 0.130 |
Why?
| | Analgesics | 1 | 2015 | 151 | 0.130 |
Why?
| | Skull Fractures | 1 | 2013 | 22 | 0.130 |
Why?
| | Follow-Up Studies | 4 | 2014 | 4888 | 0.130 |
Why?
| | Lactic Acid | 1 | 2015 | 300 | 0.130 |
Why?
| | Ophthalmology | 1 | 2013 | 40 | 0.130 |
Why?
| | Sinusitis | 1 | 2015 | 157 | 0.130 |
Why?
| | Facial Bones | 1 | 2013 | 37 | 0.130 |
Why?
| | C-Reactive Protein | 1 | 2015 | 362 | 0.130 |
Why?
| | Pain, Postoperative | 1 | 2015 | 187 | 0.130 |
Why?
| | Eye Injuries, Penetrating | 1 | 2013 | 17 | 0.130 |
Why?
| | Bites and Stings | 1 | 2013 | 36 | 0.130 |
Why?
| | Gold | 1 | 2014 | 105 | 0.130 |
Why?
| | Eye Foreign Bodies | 1 | 2013 | 24 | 0.130 |
Why?
| | Craniocerebral Trauma | 1 | 2014 | 143 | 0.120 |
Why?
| | Suture Techniques | 1 | 2013 | 127 | 0.120 |
Why?
| | Aged, 80 and over | 6 | 2015 | 6779 | 0.120 |
Why?
| | Middle Aged | 9 | 2017 | 28678 | 0.120 |
Why?
| | Adenoma | 1 | 2014 | 183 | 0.120 |
Why?
| | Dogs | 1 | 2013 | 470 | 0.120 |
Why?
| | Fellowships and Scholarships | 1 | 2013 | 207 | 0.110 |
Why?
| | Fracture Fixation, Internal | 1 | 2013 | 154 | 0.110 |
Why?
| | Glucocorticoids | 1 | 2015 | 538 | 0.110 |
Why?
| | Retinal Neoplasms | 1 | 2010 | 12 | 0.110 |
Why?
| | Retinoblastoma | 1 | 2010 | 18 | 0.110 |
Why?
| | Endophthalmitis | 1 | 2010 | 27 | 0.110 |
Why?
| | Intraoperative Complications | 1 | 2011 | 114 | 0.100 |
Why?
| | Antibodies, Monoclonal | 1 | 2017 | 1294 | 0.100 |
Why?
| | Male | 14 | 2017 | 60721 | 0.100 |
Why?
| | Persistent Fetal Circulation Syndrome | 1 | 2010 | 126 | 0.100 |
Why?
| | Education, Medical, Graduate | 1 | 2013 | 379 | 0.100 |
Why?
| | Streptococcus agalactiae | 1 | 2010 | 86 | 0.100 |
Why?
| | Blindness | 1 | 2008 | 36 | 0.090 |
Why?
| | Burkitt Lymphoma | 1 | 2008 | 64 | 0.090 |
Why?
| | Aged | 7 | 2017 | 20026 | 0.090 |
Why?
| | Adult | 9 | 2017 | 31793 | 0.090 |
Why?
| | Decision Making | 1 | 2014 | 767 | 0.080 |
Why?
| | Eyelid Neoplasms | 1 | 2006 | 5 | 0.080 |
Why?
| | Sweat Gland Neoplasms | 1 | 2006 | 6 | 0.080 |
Why?
| | Age Factors | 1 | 2014 | 3330 | 0.080 |
Why?
| | Adenocarcinoma, Mucinous | 1 | 2006 | 52 | 0.080 |
Why?
| | Biomarkers | 1 | 2015 | 3465 | 0.070 |
Why?
| | Postoperative Complications | 2 | 2013 | 2095 | 0.070 |
Why?
| | Treatment Outcome | 3 | 2017 | 8944 | 0.070 |
Why?
| | Double-Blind Method | 2 | 2017 | 1670 | 0.060 |
Why?
| | Staphylococcal Infections | 2 | 2015 | 315 | 0.060 |
Why?
| | Anti-Bacterial Agents | 3 | 2015 | 1305 | 0.060 |
Why?
| | Young Adult | 2 | 2017 | 10899 | 0.050 |
Why?
| | Prospective Studies | 3 | 2015 | 6168 | 0.050 |
Why?
| | Diplopia | 1 | 2017 | 9 | 0.040 |
Why?
| | Intention to Treat Analysis | 1 | 2017 | 74 | 0.040 |
Why?
| | Ocular Motility Disorders | 1 | 2017 | 29 | 0.040 |
Why?
| | Decompression, Surgical | 1 | 2017 | 90 | 0.040 |
Why?
| | Nasolacrimal Duct | 1 | 2015 | 6 | 0.040 |
Why?
| | Blepharoplasty | 1 | 2015 | 4 | 0.040 |
Why?
| | Pregabalin | 1 | 2015 | 7 | 0.040 |
Why?
| | Perioperative Period | 1 | 2015 | 42 | 0.040 |
Why?
| | Immunocompromised Host | 1 | 2017 | 218 | 0.040 |
Why?
| | Bone Nails | 1 | 2015 | 66 | 0.040 |
Why?
| | Diabetes Complications | 1 | 2017 | 249 | 0.040 |
Why?
| | Venous Thrombosis | 1 | 2015 | 137 | 0.030 |
Why?
| | Hyperglycemia | 1 | 2017 | 336 | 0.030 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 179 | 0.030 |
Why?
| | Administration, Oral | 1 | 2015 | 800 | 0.030 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2017 | 623 | 0.030 |
Why?
| | ROC Curve | 1 | 2014 | 486 | 0.030 |
Why?
| | Pain Measurement | 1 | 2015 | 525 | 0.030 |
Why?
| | Foreign Bodies | 1 | 2013 | 92 | 0.030 |
Why?
| | Pain Management | 1 | 2015 | 303 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2014 | 5017 | 0.030 |
Why?
| | Logistic Models | 1 | 2017 | 2049 | 0.030 |
Why?
| | Athletic Injuries | 1 | 2017 | 429 | 0.030 |
Why?
| | Microscopy, Acoustic | 1 | 2010 | 10 | 0.030 |
Why?
| | Eye Enucleation | 1 | 2010 | 12 | 0.030 |
Why?
| | Incidence | 1 | 2017 | 2453 | 0.030 |
Why?
| | Length of Stay | 1 | 2015 | 1057 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2013 | 1517 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2013 | 1240 | 0.030 |
Why?
| | Etoposide | 1 | 2008 | 166 | 0.020 |
Why?
| | Maxilla | 1 | 2007 | 35 | 0.020 |
Why?
| | Cyclophosphamide | 1 | 2008 | 236 | 0.020 |
Why?
| | Methotrexate | 1 | 2008 | 241 | 0.020 |
Why?
| | Doxorubicin | 1 | 2008 | 311 | 0.020 |
Why?
| | Colorado | 1 | 2017 | 4552 | 0.020 |
Why?
| | Quality of Life | 1 | 2017 | 2089 | 0.020 |
Why?
| | Mohs Surgery | 1 | 2006 | 22 | 0.020 |
Why?
| | Prognosis | 1 | 2014 | 3532 | 0.020 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2006 | 194 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2013 | 4550 | 0.010 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 1388 | 0.010 |
Why?
| | United States | 1 | 2013 | 12170 | 0.010 |
Why?
| | Animals | 1 | 2013 | 35194 | 0.010 |
Why?
|
|
Hink's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|